Eurofins Scientific Shares Climb 1.98% at Close, Boosted by Kepler
Eurofins Scientific's stock ended the session up 1.98% at 73.12 euros, following a positive adjustment by Kepler Cheuvreux.
Sustained Growth for Eurofins Scientific
Eurofins Scientific's stock continued its upward trend for a second consecutive session this Tuesday, January 13, 2026, closing at 73.12 euros, up from 71.70 euros the previous day. Trading volumes remained moderate, with only 0.28% of the capital traded during the day. Over the week, the laboratory analysis specialist has seen a spectacular increase of 8.91%, continuing a momentum that started in early January. The three-month performance now stands at 18.09%, while the year-over-year increase shows a remarkable rebound of 49.01%. This upward movement follows a target price increase announced on Monday by Kepler Cheuvreux, which raised its target from 72 to 81 euros, thus providing a potential upside of about 10.8% from the closing price. Additionally, the company acquired 70,000 of its own shares between January 5 and January 9, 2026, for a total amount of 4.7 million euros, demonstrating confidence in its prospects.
Technical Indicators Suggest Caution
Technically, the RSI has reached a level of 93, clearly placing the stock in an extreme overbought zone and signaling a possible pause after this surge. This high level reflects significant investor enthusiasm but traditionally calls for caution in the short term. The stock is now trading above its upper Bollinger band set at 71.75 euros, confirming the strength of the ongoing bullish movement, although this positioning may also suggest an upcoming technical consolidation. The price is significantly above its moving averages, with a 50-day moving average at 60.50 euros and a 200-day moving average at 60.24 euros, indicating a solidly upward long-term trend. The stock is also well above its support threshold at 56.74 euros and has broken through the resistance set at 71.70 euros. Morgan Stanley recently raised its price target from 61 to 64 euros on January 6, while maintaining its market-weight recommendation, reflecting a generally constructive analytical consensus on the stock.
